Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Hovione recently held the official groundbreaking for the expansion of its New Jersey Facility in East Windsor, NJ.
read more
Thursday, September 08, 2022
Hovione has expanded its continuous manufacturing offering and services. A new state-of-the-art continuous manufacturing facility is now coming online at the Loures site in Portugal.
read more
Monday, November 27, 2023
Hovione, a leading integrated Contract Development and Manufacturing Organization (CDMO) specializing in spray drying and particle engineering, has officially acquired ExtremoChem Lda (ExtremoChem), an inventive startup focused on synthesizing, ...
read more
Wednesday, November 29, 2023
Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in ...
read more
Thursday, November 30, 2023
Hovione has announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC. Intranasal drug delivery is a good alternative to conventional ...
read more
Tuesday, November 23, 2021
Hovione, a global provider of spray drying and particle engineering services announced that it is expanding its New Jersey site in East Windsor, laying the foundations for a state-of-the-art Hovione Campus.
read more
Tuesday, November 26, 2024
Hovione, announced completion of significant expansions in Europe and the USA. The investments at its East Windsor, New Jersey, and Ringaskiddy, Cork, facilities will significantly increase Hovione's global spray drying capacity and enhance the sites...
read more
Hovione announces plan to increase production capacity in oral dosage forms in Portugal, to strengthen the integrated offering.
read more
Thursday, November 11, 2021
Hovione announces that it is expanding its industrial facilities around the world to support its ambitious growth objectives.
read more
Tuesday, January 29, 2019
Hovione has issued a bond of $50 million US dollars maturing in 2033.
read more
Hovione has announced the opening of its new sales and customer support office in Osaka, Japan.
read more
Hovione announced it has signed an agreement with Dragonfly Technologies, Inc. to gain access to its micellar technology for chemistry-in-water processes, developed by Prof. Bruce Lipshutz of the University of California, Santa Barbara (UCSB).
read more
Hovione reported recent capacity expansion and future plans in its sites in Portugal, Ireland and New Jersey, with the aim to increase capacity in existing technologies
read more
Wednesday, March 07, 2018
Hovione has concluded the sale of all of the share capital of iMAX Diagnostic Imaging.
read more
Hovione Technology has secured global rights to develop and commercialize a new ultra-affordable, multi-use blister-based dry powder inhaler patented by inventor Dr. Klaus-Dieter Beller.
read more